Mavyret

(glecaprevir / pibrentasvir)
Check Coverage Restrictions
Or select your Insurance from the list below:

Dosage & Administration

Treatment-Naïve Patients

HCV GenotypeTreatment Duration
No CirrhosisCompensated Cirrhosis
(Child-Pugh A)
1, 2, 3, 4, 5, or 68 weeks8 weeks

Treatment-Experienced Patients

  Treatment Duration
HCV
Genotype
Patients Previously
Treated With a

Regimen Containing:
No
Cirrhosis
Compensated
Cirrhosis

(Child-Pugh A)
1An NS5A inhibitor1 without prior treatment with an NS3/4A protease inhibitor (PI) 16 weeks16 weeks
An NS3/4A PI2 without prior treatment with an NS5A inhibitor 12 weeks12 weeks
1, 2, 4, 5, or 6PRS3  8 weeks12 weeks
3PRS316 weeks16 weeks




Mavyret Prescribing Information

Mavyret Prior Authorization Resources

Mavyret PubMed™ News

    Mavyret Patient Education

    Patient toolkit